HOME >> BIOLOGY >> NEWS
JCI table of contents November, 2005

EDITOR'S PICK
A new step towards an AIDS vaccine

Progressive disease after HIV infection is inversely correlated with the presence of plasmacytoid dendritic cells (pDCs), a subset of the dendritic cell family and the major producers of type 1 interferon in the body. High numbers of pDCs is related to successful control of HIV. In a paper appearing online on October 13 in advance of print publication of the November issue of the Journal of Clinical Investigation, Nina Bhardwaj and colleagues from New York University report the mechanisms by which HIV-1 activates human pDCs.

The authors show that pDC activation by HIV-1 requires at least two interactions between the cell and virus. Initially, envelope-CD4 interactions mediate the endocytosis of HIV-1. Next, viral nucleic acids, particularly RNA, stimulate pDCs through Toll-like receptors.

A decrease of blood pDC frequency is typically observed in chronic infections due to HIV-1 and correlates with high viral load, reduced CD4 counts and susceptibility to opportunistic infections, and is only partially reverted by anti-retroviral therapy. By identifying the active component of HIV-1 which stimulates pDC function, and consequently other antigen presenting cell function, the authors have recognized an important pathway whereby DC function can be targeted in the design of efficient vaccines or immunotherapies for HIV.

TITLE: Endocytosis of HIV-1 Activates Plasmacytoid Dendritic Cells via Toll-Like Receptor -viral RNA interactions

AUTHOR CONTACT:
Nina Bhardwaj
New York University School of Medicine, New York, NY USA
Phone: 1 212 263 5814; Fax: 1 212 263 6729; E-mail: bhardn02@popmail.med.nyu.edu

View the PDF of this article at: https://www.the-jci.org/article.php?id=26032

EDITOR'S PICK'"/>

Contact: Stacie Bloom
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
13-Oct-2005


Page: 1 2 3 4 5 6 7

Related biology news :

1. Antioxidant overload may underlie a heritable human disease
2. JCI table of contents: Aug. 9, 2007
3. JCI table of contents: August 1, 2007
4. US Department of Defense awards $1.6 million for implantable biochip research
5. More fish oil, less vegetable oil, better for your health
6. JCI table of contents -- July 26, 2007
7. JCI table of contents: July 19, 2007
8. JCI table of contents: July 12, 2007
9. JCI table of contents: June 21, 2007
10. JCI table of contents: June 14, 2007
11. Food safety begins as vegetables grow

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/8/2019)... ... May 08, 2019 , ... FISO Technologies proudly ... microns and a lead-in fiber of 100 microns. With dimensions smaller than any ... itself as the world leader in the development of fiber optic sensors & ...
(Date:5/7/2019)... ... May 07, 2019 , ... AMGtime will be ... Entertainment Center from May 15- 17. At booth #226, AMGtime will be showcasing ... software, biometric hardware, mobile apps, specialized industry solutions, advanced add-on modules, seamless integrations, ...
(Date:5/2/2019)... ... April 30, 2019 , ... Global molecular ... today that Holotype HLA and other Omixon products will be featured in 12 ... (EFI) in Lisbon, Portugal. Among the major scientific events, Omixon’s Lunch ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... SANTA BARBARA, Calif. (PRWEB) , ... April 09, ... ... global professional services firm focused on increasing the capacity of life sciences organizations ... to its Cloud Assurance platform in the past 12 months. , ...
(Date:4/9/2019)... ... April 09, 2019 , ... The American Society ... of the Society's leadership team, including a new addition to the presidential line of ... their peers to join the Society's leadership team for a three-year term (2019-2021). , ...
(Date:4/8/2019)... ... , ... US Capital Global Securities , an affiliate of US Capital ... privately held pharmaceutical company, S1 Biopharma (“S1”). , S1 has a pipeline of drugs ... dysfunction disorder and is ready to begin phase 2b trials. In phase 2a trials, ...
(Date:4/4/2019)... , ... April 02, 2019 , ... ... solutions, announced it would be releasing it’s latest field-ready solution for performing PCR, ... Biomeme’s next-gen thermocycler Franklin™ pays homage to Rosland Franklin, an English chemist and ...
Breaking Biology Technology:
Cached News: